Hua Medicine (shanghai) Ltd.
Patents = 13
Forward Citations = 5
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
15 inventors (with patents filed for the assignee):
Hua Medicine (Shanghai) Ltd. is a clinical-stage biopharmaceutical company developing a portfolio of novel, innovative therapies for the treatment of diabetes and CNS disorders. Their lead product is dorzagliatin, a first-in-class, glucokinase activator for the treatment of type 2 diabetes. Hua Medicine is committed to improving patient outcomes and quality of life by leveraging cutting-edge science and technology.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com